PetMed Express, Inc. (PETS)
NASDAQ: PETS · IEX Real-Time Price · USD
4.020
-0.030 (-0.74%)
At close: Apr 26, 2024, 4:00 PM
4.100
+0.080 (1.99%)
After-hours: Apr 26, 2024, 7:56 PM EDT

PetMed Express Revenue

PetMed Express had revenue of $276.97M in the twelve months ending December 31, 2023, with 6.92% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $65.32M with 10.95% year-over-year growth. In the fiscal year ending March 31, 2023, PetMed Express had annual revenue of $256.58M, a decrease of -5.77%.

Revenue (ttm)
$276.97M
Revenue Growth
+6.92%
P/S Ratio
0.31
Revenue / Employee
$917,109
Employees
302
Market Cap
85.02M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2023256.58M-15.70M-5.77%
Mar 31, 2022272.28M-31.30M-10.31%
Mar 31, 2021303.58M19.46M6.85%
Mar 31, 2020284.13M706.00K0.25%
Mar 31, 2019283.42M9.62M3.51%
Mar 31, 2018273.80M24.62M9.88%
Mar 31, 2017249.18M14.49M6.18%
Mar 31, 2016234.68M5.29M2.31%
Mar 31, 2015229.40M-4.00M-1.71%
Mar 31, 2014233.39M5.56M2.44%
Mar 31, 2013227.83M-10.42M-4.37%
Mar 31, 2012238.25M6.61M2.85%
Mar 31, 2011231.64M-6.62M-2.78%
Mar 31, 2010238.27M18.85M8.59%
Mar 31, 2009219.41M31.08M16.50%
Mar 31, 2008188.34M26.09M16.08%
Mar 31, 2007162.25M24.66M17.93%
Mar 31, 2006137.58M29.23M26.97%
Mar 31, 2005108.36M14.36M15.28%
Mar 31, 200493.99M39.02M70.98%
Mar 31, 200354.97M22.95M71.66%
Mar 31, 200232.03M22.02M220.06%
Mar 31, 200110.01M-4.67M-31.82%
Mar 31, 200014.68M4.45M43.55%
Mar 31, 199910.22M6.73M192.66%
Mar 31, 19983.49M2.89M480.14%
Mar 31, 1997602.19K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.11B
The Oncology Institute 324.24M
ProPhase Labs 44.38M
Forian 20.48M
HOOKIPA Pharma 20.13M
Curis 10.02M
BeyondSpring 1.55M
Genelux 170.00K
Revenue Rankings